Implementable assay for monitoring minimum residual disease after radical treatment for colorectal cancer.
Nakano T, Takao S, Dairaku K, Uno N, Low SA, Hashimoto M, Tsuda Y, Hisamatsu Y, Toshima T, Yonemura Y, Masuda T, Eto K, Ikegami T, Fukunaga Y, Niida A, Nagayama S, Mimori K.
Nakano T, et al.
Cancer Sci. 2024 Mar 26. doi: 10.1111/cas.16149. Online ahead of print.
Cancer Sci. 2024.
PMID: 38531808
Free article.